Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized scleroderma. [electronic resource]
Producer: 20121105Description: 599-609 p. digitalISSN:- 1365-2230
- Adolescent
- Adult
- Aged
- Collagen Type II -- administration & dosage
- Double-Blind Method
- Down-Regulation
- Female
- Flow Cytometry
- Forkhead Transcription Factors -- metabolism
- Humans
- Immunohistochemistry
- Injections, Subcutaneous
- Interleukin-17 -- metabolism
- Interleukins -- metabolism
- Male
- Middle Aged
- Prospective Studies
- Scleroderma, Localized -- drug therapy
- T-Lymphocytes -- metabolism
- Transforming Growth Factor beta1 -- metabolism
- Young Adult
- Interleukin-22
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.